These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8395247)

  • 1. Structure and activity relationships leading to the discovery of ICI D2138, a selective, potent and orally active inhibitor of 5-lipoxygenase.
    Crawley GC; Bird TG; Bruneau P; Dowell RI; Edwards PN; Foster SJ; Girodeau JM; McMillan RM; Walker ER; Waterson D
    J Lipid Mediat; 1993; 6(1-3):249-57. PubMed ID: 8395247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methoxytetrahydropyrans. A new series of selective and orally potent 5-lipoxygenase inhibitors.
    Crawley GC; Dowell RI; Edwards PN; Foster SJ; McMillan RM; Walker ER; Waterson D; Bird TG; Bruneau P; Giroaeau JM
    J Med Chem; 1992 Jul; 35(14):2600-9. PubMed ID: 1321908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-clinical pharmacology of ICI D2138, a potent orally-active non-redox inhibitor of 5-lipoxygenase.
    McMillan RM; Spruce KE; Crawley GC; Walker ER; Foster SJ
    Br J Pharmacol; 1992 Dec; 107(4):1042-7. PubMed ID: 1334748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-[5-Fluoro-3-[4-(2-methyl-1H-imidazol-1-yl)benzyloxy]phenyl]-3,4,5,6- tetrahydro-2H-pyran-4-carboxamide, an orally active inhibitor of 5-lipoxygenase with improved pharmacokinetic and toxicology characteristics.
    Mano T; Okumura Y; Sakakibara M; Okumura T; Tamura T; Miyamoto K; Stevens RW
    J Med Chem; 2004 Jan; 47(3):720-5. PubMed ID: 14736252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-Methoxy-2-methyltetrahydropyrans: chiral leukotriene biosynthesis inhibitors, related to ICI D2138, which display enantioselectivity.
    Crawley GC; Briggs MT; Dowell RI; Edwards PN; Hamilton PM; Kingston JF; Oldham K; Waterson D; Whalley DP
    J Med Chem; 1993 Jan; 36(2):295-6. PubMed ID: 8380872
    [No Abstract]   [Full Text] [Related]  

  • 6. 5-Lipoxygenase inhibitors: synthesis and structure-activity relationships of a series of 1-aryl-2H,4H-tetrahydro-1,2,4-triazin-3-ones.
    Bhatia PA; Brooks CD; Basha A; Ratajczyk JD; Gunn BP; Bouska JB; Lanni C; Young PR; Bell RL; Carter GW
    J Med Chem; 1996 Sep; 39(20):3938-50. PubMed ID: 8831760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Lipoxygenase inhibitors: convenient synthesis of 4-[3-(4-heterocyclylphenylthio)phenyl]-3,4,5,6-tetrahydro-2H-pyran-4-carboxamide analogues.
    Mano T; Stevens RW; Okumura Y; Kawai M; Okumura T; Sakakibara M
    Bioorg Med Chem Lett; 2005 May; 15(10):2611-5. PubMed ID: 15863327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational analysis of 5-lipoxygenase inhibitors: role of the substituents in chiral recognition and on the active conformations of the (methoxyalkyl)thiazole and methoxytetrahydropyran series.
    Lambert-van der Brempt C; Bruneau P; Lamorlette MA; Foster SJ
    J Med Chem; 1994 Jan; 37(1):113-24. PubMed ID: 8289184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naphthalenic lignan lactones as selective, nonredox 5-lipoxygenase inhibitors. Synthesis and biological activity of (methoxyalkyl)thiazole and methoxytetrahydropyran hybrids.
    Ducharme Y; Brideau C; Dubé D; Chan CC; Falgueyret JP; Gillard JW; Guay J; Hutchinson JH; McFarlane CS; Riendeau D
    J Med Chem; 1994 Feb; 37(4):512-8. PubMed ID: 8120869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 5-lipoxygenase inhibitors ZD2138 and ZM230487 are potent and selective inhibitors of several antigen-induced guinea-pig pulmonary responses.
    Kusner EJ; Buckner CK; Dea DM; DeHaas CJ; Marks RL; Krell RD
    Eur J Pharmacol; 1994 May; 257(3):285-92. PubMed ID: 7522174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dioxabicyclooctanyl naphthalenenitriles as nonredox 5-lipoxygenase inhibitors: structure-activity relationship study directed toward the improvement of metabolic stability.
    Delorme D; Ducharme Y; Brideau C; Chan CC; Chauret N; Desmarais S; Dubé D; Falgueyret JP; Fortin R; Guay J; Hamel P; Jones TR; Lépine C; Li C; McAuliffe M; McFarlane CS; Nicoll-Griffith DA; Riendeau D; Yergey JA; Girard Y
    J Med Chem; 1996 Sep; 39(20):3951-70. PubMed ID: 8831761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (Methoxyalkyl)thiazoles: a new series of potent, selective, and orally active 5-lipoxygenase inhibitors displaying high enantioselectivity.
    Bird ; Bruneau P; Crawley GC; Edwards MP; Foster SJ; Girodeau JM; Kingston JF; McMillan RM
    J Med Chem; 1991 Jul; 34(7):2176-86. PubMed ID: 1648621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The discovery of a potent and selective lethal factor inhibitor for adjunct therapy of anthrax infection.
    Xiong Y; Wiltsie J; Woods A; Guo J; Pivnichny JV; Tang W; Bansal A; Cummings RT; Cunningham BR; Friedlander AM; Douglas CM; Salowe SP; Zaller DM; Scolnick EM; Schmatz DM; Bartizal K; Hermes JD; MacCoss M; Chapman KT
    Bioorg Med Chem Lett; 2006 Feb; 16(4):964-8. PubMed ID: 16338135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of 5-lipoxygenase: development of hydroxamic acids and hydroxyureas as potential therapeutic agents.
    Salmon JA; Jackson WP; Garland LG
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():109-12. PubMed ID: 1847758
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthesis and biological evaluation of 2,3,5-trimethyl-6-(3-pyridylmethyl)-1,4-benzoquinone (CV-6504), a dual inhibitor of TXA2 synthase and 5-lipoxygenase with scavenging activity of active oxygen species (AOS).
    Terao S; Ohkawa S; Terashita Z; Shibouta Y; Nishikawa K
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():173-6. PubMed ID: 1847762
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthesis and biological evaluation of N-aryl-4-aryl-1,3-thiazole-2-amine derivatives as direct 5-lipoxygenase inhibitors.
    Suh J; Yum EK; Cheon HG; Cho YS
    Chem Biol Drug Des; 2012 Jul; 80(1):89-98. PubMed ID: 22404847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent and selective 5-LO inhibitor bearing benzothiophene pharmacophore: discovery of MK-5286.
    Li L; Berthelette C; Chateauneuf A; Ouellet M; Sturino CF; Wang Z
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7440-3. PubMed ID: 21044840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel and potent inhibitors of stearoyl-CoA desaturase-1. Part I: Discovery of 3-(2-hydroxyethoxy)-4-methoxy-N-[5-(3-trifluoromethylbenzyl)thiazol-2-yl]benzamide.
    Uto Y; Ogata T; Harada J; Kiyotsuka Y; Ueno Y; Miyazawa Y; Kurata H; Deguchi T; Watanabe N; Takagi T; Wakimoto S; Okuyama R; Abe M; Kurikawa N; Kawamura S; Yamato M; Osumi J
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4151-8. PubMed ID: 19540759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of 2-phenylpyran-4-ones: a new class of orally active cyclooxygenase-2 inhibitors.
    Caturla F; Jiménez JM; Godessart N; Amat M; Cárdenas A; Soca L; Beleta J; Ryder H; Crespo MI
    J Med Chem; 2004 Jul; 47(15):3874-86. PubMed ID: 15239665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-651,392: a novel, potent and selective 5-lipoxygenase inhibitor.
    Guindon Y; Girard Y; Maycock A; Ford-Hutchinson AW; Atkinson JG; Bélanger PC; Dallob A; DeSousa D; Dougherty H; Egan R
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():554-7. PubMed ID: 2821766
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.